Genedrive PLC Notice of Results (8079E)
14 February 2018 - 6:00PM
UK Regulatory
TIDMGDR
RNS Number : 8079E
Genedrive PLC
14 February 2018
For release: 14 February 2018
genedrive plc ("genedrive" or the "Company")
Notice of Interim Results
genedrive plc, (AIM: GDR), the near patient molecular
diagnostics company, will be announcing its interim results for the
six months ending 31 December 2017 on Tuesday 20 March.
David Budd, Chief Executive Officer, and Matthew Fowler, Chief
Financial Officer, will host a presentation and simultaneous live
conference call for analysts, followed by a Q&A session, at
9:30am on the day of the results. The presentation will be held at
85 Gresham Street, London, EC2R 7HE.
- Ends -
For further details please contact:
genedrive plc
David Budd: CEO +44 (0)161 989 0245
Matthew Fowler: CFO
Peel Hunt LLP
James Steel +44 (0)207 418 8900
Oliver Jackson
Consilium Strategic Communications
Chris Gardner +44 (0)203 709 5700
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com
Notes to Editors
About genedrive plc
genedrive plc is a molecular diagnostics company developing and
commercialising a low cost, rapid, versatile, simple to use and
robust point of need molecular diagnostics platform for the
diagnosis of infectious diseases and for use in patient
stratification (genotyping), pathogen detection and other
indications. The Genedrive(R) platform and MTB/RIF assay has been
launched in India and a Genedrive(R) HCV test has received CE-IVD
Certification and has been launched in Africa. genedrive has
distribution agreements with subsidiaries of Sysmex Corporation for
the distribution of the Genedrive(R) platform in the EMEA and Asia
Pacific regions.
Further details can be found at: www.genedriveplc.com and
www.genedrive.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORTIMMTMBMBMRP
(END) Dow Jones Newswires
February 14, 2018 02:00 ET (07:00 GMT)
Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2024 to May 2024
Genedrive (LSE:GDR)
Historical Stock Chart
From May 2023 to May 2024